PT1385518E - Compostos de benzimidazolona - Google Patents

Compostos de benzimidazolona Download PDF

Info

Publication number: PT1385518E
Authority: PT; Portugal
Prior art keywords: benzimidazolone compounds; compounds; benzimidazolone; analgetics; formula
Prior art date: 2001-04-18

Application number

PT02764243T

Other languages

English (en)

Inventor

Zhengming Chen

R Richard Goehring

Donald Kyle

Sam Victory

Original Assignee

Euro Celtique Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-18

Filing date

2002-04-18

Publication date

2008-10-07

2002-04-18 Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa

2008-10-07 Publication of PT1385518E publication Critical patent/PT1385518E/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Psychiatry (AREA)
Hematology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Obesity (AREA)
Anesthesiology (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PT02764243T 2001-04-18 2002-04-18 Compostos de benzimidazolona PT1385518E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US28466501P	2001-04-18	2001-04-18

Publications (1)

Publication Number	Publication Date
PT1385518E true PT1385518E (pt)	2008-10-07

Family

ID=23091051

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PT08011371T PT1975164E (pt)	2001-04-18	2002-04-18	Compostos de octa-hidrobenzimidazolona utilizados como analgésicos
PT02764243T PT1385518E (pt)	2001-04-18	2002-04-18	Compostos de benzimidazolona

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PT08011371T PT1975164E (pt)	2001-04-18	2002-04-18	Compostos de octa-hidrobenzimidazolona utilizados como analgésicos

Country Status (13)

Country	Link
US (2)	US6872733B2 (pt)
EP (3)	EP2172468A1 (pt)
JP (1)	JP4401076B2 (pt)
AT (2)	ATE403431T1 (pt)
AU (1)	AU2002338424B2 (pt)
CA (1)	CA2444489C (pt)
CY (2)	CY1108456T1 (pt)
DE (2)	DE60228072D1 (pt)
DK (2)	DK1975164T3 (pt)
ES (2)	ES2340441T3 (pt)
PT (2)	PT1975164E (pt)
SI (2)	SI1385518T1 (pt)
WO (1)	WO2002085361A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1491212B1 (en)	2002-03-29	2012-08-08	Mitsubishi Tanabe Pharma Corporation	Remedy for sleep disturbance
PL2574341T3 (pl)	2004-03-29	2017-09-29	University Of South Florida	Efektywne leczenie guzów i raka fosforanem tricyrybiny
US20110008327A1 (en)	2004-03-29	2011-01-13	Cheng Jin Q	Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
US20100028339A1 (en) *	2004-03-29	2010-02-04	Cheng Jin Q	Compositions including triciribine and trastuzumab and methods of use thereof
US20100173864A1 (en)	2004-03-29	2010-07-08	Cheng Jin Q	Compositions including triciribine and one or more platinum compounds and methods of use thereof
US20100009928A1 (en)	2004-03-29	2010-01-14	Cheng Jin Q	Compositions including triciribine and taxanes and methods of use thereof
US20100009929A1 (en)	2004-03-29	2010-01-14	Cheng Jin Q	Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
AU2006296369B2 (en) *	2005-09-30	2012-12-20	Glaxo Group Limited	Compounds which have activity at M1 receptor and their uses in medicine
ES2391107T3 (es) *	2005-09-30	2012-11-21	Glaxo Group Limited	Compuestos que tienen actividad en el receptor M1 y sus usos en medicina
JP5209479B2 (ja) *	2005-09-30	2013-06-12	グラクソグループリミテッド	Ｍ１受容体にて活性を有するベンゾイミダゾロン類
CN1870631B (zh) *	2005-11-11	2010-04-14	华为技术有限公司	媒体网关的门控方法
TW200813018A (en)	2006-06-09	2008-03-16	Astrazeneca Ab	Novel compounds
US20080051380A1 (en)	2006-08-25	2008-02-28	Auerbach Alan H	Methods and compositions for treating cancer
SI2076506T1 (sl) *	2007-01-16	2011-01-31	Purdue Pharma Lp	Heterociklično substituirani piperidini kot ORL-1 ligandi
GB0706188D0 (en) *	2007-03-29	2007-05-09	Glaxo Group Ltd	Compounds
EP2433936A1 (en) *	2007-08-31	2012-03-28	Purdue Pharma LP	Substituted-quinoxaline-type-piperidine compounds and the uses thereof
US8119661B2 (en)	2007-09-11	2012-02-21	Astrazeneca Ab	Piperidine derivatives and their use as muscarinic receptor modulators
GB0718415D0 (en) *	2007-09-20	2007-10-31	Glaxo Group Ltd	Compounds
MX2011000872A (es)	2008-07-21	2011-07-29	Purdue Pharma Lp	Compuestos de piperidina puenteada tipo quinoxalina sustituida y los usos de los mismos.
US9951038B2 (en)	2012-12-27	2018-04-24	Purdue Pharma L.P.	Quinazolin-4(3H)-one-type piperidine compounds and uses thereof
WO2014102594A2 (en)	2012-12-27	2014-07-03	Purdue Pharma L.P.	Substituted benzimidazole-type piperidine compounds and uses thereof
WO2014102590A1 (en)	2012-12-27	2014-07-03	Purdue Pharma L.P.	Substituted piperidin-4-amino-type compounds and uses thereof
WO2014102588A2 (en)	2012-12-27	2014-07-03	Purdue Pharma L.P.	Indole and indoline-type piperidine compounds and uses thereof
US20180028521A1 (en)	2016-07-29	2018-02-01	Janssen Pharmaceutica Nv	Methods of Treating Prostate Cancer

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3161645A (en)	1962-12-18	1964-12-15	Res Lab Dr C Janssen N V	1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds
US3318900A (en)	1964-05-06	1967-05-09	Janssen Pharmaceutica Nv	Derivatives of benzimidazolinyl piperidine
US3325499A (en)	1964-11-02	1967-06-13	Mcneilab Inc	1-(1-hydrocarbyl-4-piperdyl)-2-indolinone
DE2609645A1 (de)	1976-03-09	1977-09-15	Boehringer Sohn Ingelheim	Aminoalkylheterocyclen
US4329353A (en)	1980-10-22	1982-05-11	Janssen Pharmaceutica, N.V.	1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and pharmaceutical compositions thereof
US4410528A (en)	1980-05-16	1983-10-18	Kyowa Hakko Kogyo Co., Ltd.	Hypotensive piperidine derivatives
JPS58180481A (ja)	1982-04-15	1983-10-21	Kyowa Hakko Kogyo Co Ltd	新規なピペリジン誘導体
JPS60120872A (ja)	1983-12-01	1985-06-28	Kyowa Hakko Kogyo Co Ltd	新規なヘテロ環状化合物及び強心剤
EP0755392A4 (en)	1994-04-14	1997-05-02	Merck & Co Inc	ALPHA1C ADRENERGIC RECEPTOR ANTAGONISTS
FR2722190B1 (fr)	1994-07-05	1996-10-04	Sanofi Sa	Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
US5767118A (en)	1994-10-26	1998-06-16	Merck & Co., Inc.	4-Heterocyclic peperidines promote release of growth hormone
US5574044A (en)	1994-10-27	1996-11-12	Merck & Co., Inc.	Muscarine antagonists
US6136839A (en)	1995-06-12	2000-10-24	G. D. Searle & Co.	Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
AU6943996A (en)	1995-09-13	1997-04-01	Kyowa Hakko Kogyo Co. Ltd.	Phenylpiperidine derivatives
EP0898568B1 (en)	1996-04-19	2006-10-04	Neurosearch A/S	1-(4-piperidyl)-benzimidazoles having neurotrophic activity
US6063796A (en)	1997-04-04	2000-05-16	Merck & Co., Inc.	Somatostatin agonists
ATE276242T1 (de)	1997-05-30	2004-10-15	Banyu Pharma Co Ltd	2-oxoimidazol-derivate
JPH10330377A (ja)	1997-06-02	1998-12-15	Kyowa Hakko Kogyo Co Ltd	ピペリジン誘導体
US6166037A (en)	1997-08-28	2000-12-26	Merck & Co., Inc.	Pyrrolidine and piperidine modulators of chemokine receptor activity
SI0921125T1 (en)	1997-12-05	2002-04-30	F. Hoffmann-La Roche Ag	1,3,8-Triazaspiro(4,5)decan-4-on derivatives
US6166209A (en)	1997-12-11	2000-12-26	Hoffmann-La Roche Inc.	Piperidine derivatives
DK1049689T3 (da)	1998-01-19	2002-07-22	Pfizer	4-(2-keto-1-benzimidazolinyl)piperidinderivater som ORL1-receptoragonister
WO1999048492A1 (fr)	1998-03-26	1999-09-30	Japan Tobacco Inc.	Derives d'amide et antagonistes de nociceptine
AU3809999A (en)	1998-05-18	1999-12-06	Novo Nordisk A/S	Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
ID29137A (id)	1998-07-27	2001-08-02	Schering Corp	Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1
US6262066B1 (en)	1998-07-27	2001-07-17	Schering Corporation	High affinity ligands for nociceptin receptor ORL-1
MA26659A1 (fr) *	1998-08-06	2004-12-20	Pfizer	Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
SE9904652D0 (sv)	1999-12-17	1999-12-17	Astra Pharma Prod	Novel Compounds
WO2002020011A2 (en)	2000-09-06	2002-03-14	Ortho Mcneil Pharmaceutical, Inc.	A method for treating allergies using substituted pyrazoles

2002
- 2002-04-18 DK DK08011371.5T patent/DK1975164T3/da active
- 2002-04-18 PT PT08011371T patent/PT1975164E/pt unknown
- 2002-04-18 SI SI200230749T patent/SI1385518T1/sl unknown
- 2002-04-18 PT PT02764243T patent/PT1385518E/pt unknown
- 2002-04-18 US US10/126,437 patent/US6872733B2/en not_active Expired - Lifetime
- 2002-04-18 DE DE60228072T patent/DE60228072D1/de not_active Expired - Lifetime
- 2002-04-18 EP EP10000601A patent/EP2172468A1/en not_active Withdrawn
- 2002-04-18 WO PCT/US2002/012375 patent/WO2002085361A1/en active IP Right Grant
- 2002-04-18 ES ES08011371T patent/ES2340441T3/es not_active Expired - Lifetime
- 2002-04-18 AT AT02764243T patent/ATE403431T1/de not_active IP Right Cessation
- 2002-04-18 CA CA2444489A patent/CA2444489C/en not_active Expired - Fee Related
- 2002-04-18 JP JP2002582934A patent/JP4401076B2/ja not_active Expired - Fee Related
- 2002-04-18 ES ES02764243T patent/ES2312616T3/es not_active Expired - Lifetime
- 2002-04-18 DK DK02764243T patent/DK1385518T3/da active
- 2002-04-18 SI SI200230894T patent/SI1975164T1/sl unknown
- 2002-04-18 AU AU2002338424A patent/AU2002338424B2/en not_active Ceased
- 2002-04-18 AT AT08011371T patent/ATE456564T1/de not_active IP Right Cessation
- 2002-04-18 EP EP08011371A patent/EP1975164B1/en not_active Expired - Lifetime
- 2002-04-18 DE DE60235274T patent/DE60235274D1/de not_active Expired - Lifetime
- 2002-04-18 EP EP02764243A patent/EP1385518B1/en not_active Expired - Lifetime
2005
- 2005-03-28 US US11/091,229 patent/US20050192307A1/en not_active Abandoned
2008
- 2008-10-27 CY CY20081101210T patent/CY1108456T1/el unknown
2010
- 2010-04-14 CY CY20101100336T patent/CY1110000T1/el unknown

Also Published As

Publication number	Publication date
EP2172468A1 (en)	2010-04-07
PT1975164E (pt)	2010-04-20
US20050192307A1 (en)	2005-09-01
SI1975164T1 (sl)	2010-05-31
ES2340441T3 (es)	2010-06-02
DE60228072D1 (de)	2008-09-18
EP1975164B1 (en)	2010-01-27
ATE456564T1 (de)	2010-02-15
JP4401076B2 (ja)	2010-01-20
DE60235274D1 (de)	2010-03-18
EP1975164A3 (en)	2008-10-08
WO2002085361A1 (en)	2002-10-31
ES2312616T3 (es)	2009-03-01
CA2444489C (en)	2010-06-22
EP1385518A1 (en)	2004-02-04
JP2004531532A (ja)	2004-10-14
DK1975164T3 (da)	2010-05-25
DK1385518T3 (da)	2008-10-27
US6872733B2 (en)	2005-03-29
SI1385518T1 (sl)	2009-02-28
US20030008886A1 (en)	2003-01-09
CA2444489A1 (en)	2002-10-31
EP1385518B1 (en)	2008-08-06
AU2002338424B2 (en)	2005-04-21
EP1975164A2 (en)	2008-10-01
CY1110000T1 (el)	2012-05-23
ATE403431T1 (de)	2008-08-15
EP1385518A4 (en)	2005-10-05
CY1108456T1 (el)	2012-05-23

Publication	Publication Date	Title
SI1385518T1 (sl)	2009-02-28	Benzimidazolonske spojine
SI1385514T1 (sl)	2009-04-30	Spiroindenske in spiroindanske spojine
DE69803907T2 (de)	2002-06-27	Fungizide 2-Methoxybenzophenone
ATE404528T1 (de)	2008-08-15	7,9 substituierte tetracyclinverbindungen
ZA200309887B (en)	2004-07-20	Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
HK1062885A1 (en)	2004-12-03	Spiropyrazole compounds
MXPA02009380A (es)	2004-08-12	Composicion de tenido que contiene un compuesto de para-aminofenol o para-fenilendiamina sustituido por un radical silanico.
MXPA04004937A (es)	2004-08-11	Proceso para preparar 3,3??,3,6??,-tetraalquil-2,2??-bifenoles y 3,??,6,??-tetraalquil-5,??-dihalo-2,??-bifenoles.
EP1186616A4 (en)	2005-05-18	ANTIFUCOIDAN ANTIBODY
EP1557407A4 (en)	2006-11-15	NEW ALPHA-CETOAMIDE DERIVATIVE AND USE THEREOF
WO1999046263A3 (de)	1999-11-11	Fungizide benzoheterocyclyloxime